$BEAT CardioNet, Inc. Announces Launch of MCOTos 2
Post# of 102228
$BEAT CardioNet, Inc. Announces Launch of MCOTos 2:1 Device
CardioNet, Inc. (Nasdaq:BEAT) ("CardioNet"), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today the launch of the MCOTos 2:1 device, providing both MCOTTM and wEvent monitoring capability in a single device. This added feature provides increased flexibility and convenience to both physicians and patients.
Joseph Capper, President and Chief Executive Officer of CardioNet, commented: "As part of our CardioNet Comprehensive strategy, we continue to develop solutions designed to serve all of the cardiac monitoring needs of our patients and practices. Consistent with this strategy, we are pleased to announce the latest addition to our cardiac monitoring device line-up, the MCOTos 2:1. With this device, we are able to offer either MCOTTM or wEvent monitoring, on demand, in the convenience of a single device. By combining these two life-saving technologies in one system, we are able to monitor patients more effectively, while providing increased efficiency and ease of use to our physicians. As evidenced with this latest introduction, we remain committed to providing our customers the best wireless cardiac monitoring solutions on the market."
http://www.globenewswire.com/news-release/201...evice.html
(0)
(0)